Personnel

Electroporation-focused company names David J. Pyrce chief business officer

Published in Gene Therapy Weekly, November 27th, 2003

Inovio, AS, a biotechnology company specializing in the development and use of electroporation-based drug delivery systems for in vivo delivery of genes and other biomolecules, announced the appointment of veteran healthcare executive David J. Pyrce to the position of chief business officer.

An executive with more than 25 years of diverse senior management experience in the healthcare industry, including business development, investment banking, sales, and marketing, Pyrce will be responsible for strategy and business development and leading the firm's strategic partnering efforts.

"David's arrival further strengthens our senior management team as we...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2003-11-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry